Global Prostate Cancer Antigen 3 Test Competitive Landscape Professional Research Report 2024

Research Summary

The Prostate Cancer Antigen 3 (PCA3) test is a diagnostic test used to help detect prostate cancer, particularly in men with elevated prostate-specific antigen (PSA) levels or abnormal digital rectal examination (DRE) results. Unlike the PSA test, which measures the levels of a protein produced by both normal and cancerous prostate cells, the PCA3 test specifically measures the levels of PCA3 RNA, a non-coding RNA molecule that is overexpressed in prostate cancer cells. The PCA3 test is typically performed on a urine sample collected after a digital rectal examination (DRE). Higher levels of PCA3 RNA in the urine sample may indicate the presence of prostate cancer. The PCA3 test is often used in conjunction with other diagnostic tests, such as PSA testing and prostate biopsy, to help assess the risk of prostate cancer and guide treatment decisions. While the PCA3 test can provide valuable information, it is not a standalone test for diagnosing prostate cancer and should be interpreted in conjunction with other clinical findings.

According to DIResearch's in-depth investigation and research, the global Prostate Cancer Antigen 3 Test market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Prostate Cancer Antigen 3 Test include MDxHealth, Myriad Genetics, Inc, Abbott, F. Hoffmann-La Roche Ltd, Siemens, OPKO Health, Inc, Genomic Health, BD, Agilent Technologies, Inc, Danaher etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Prostate Cancer Antigen 3 Test. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Prostate Cancer Antigen 3 Test market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Prostate Cancer Antigen 3 Test market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Prostate Cancer Antigen 3 Test industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Prostate Cancer Antigen 3 Test Include:

MDxHealth

Myriad Genetics, Inc

Abbott

F. Hoffmann-La Roche Ltd

Siemens

OPKO Health, Inc

Genomic Health

BD

Agilent Technologies, Inc

Danaher

Prostate Cancer Antigen 3 Test Product Segment Include:

RT-PCR

ELISA Test

Micro-neutralization Assays

Prostate Cancer Antigen 3 Test Product Application Include:

Hospital

Specialist Clinic

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Prostate Cancer Antigen 3 Test Industry PESTEL Analysis

Chapter 3: Global Prostate Cancer Antigen 3 Test Industry Porter's Five Forces Analysis

Chapter 4: Global Prostate Cancer Antigen 3 Test Major Regional Market Size and Forecast Analysis

Chapter 5: Global Prostate Cancer Antigen 3 Test Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Prostate Cancer Antigen 3 Test Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Prostate Cancer Antigen 3 Test Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Prostate Cancer Antigen 3 Test Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Prostate Cancer Antigen 3 Test Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Prostate Cancer Antigen 3 Test Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Prostate Cancer Antigen 3 Test Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Prostate Cancer Antigen 3 Test Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Prostate Cancer Antigen 3 Test Market Overview

1.1 Product Definition and Statistical Scope

1.2 Prostate Cancer Antigen 3 Test Product by Type

1.2.1 Global Prostate Cancer Antigen 3 Test Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 RT-PCR

1.2.3 ELISA Test

1.2.4 Micro-neutralization Assays

1.3 Prostate Cancer Antigen 3 Test Product by Application

1.3.1 Global Prostate Cancer Antigen 3 Test Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hospital

1.3.3 Specialist Clinic

1.3.4 Other

1.4 Global Prostate Cancer Antigen 3 Test Market Revenue Analysis (2019-2030)

1.5 Prostate Cancer Antigen 3 Test Market Development Status and Trends

1.5.1 Prostate Cancer Antigen 3 Test Industry Development Status Analysis

1.5.2 Prostate Cancer Antigen 3 Test Industry Development Trends Analysis

2 Prostate Cancer Antigen 3 Test Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Prostate Cancer Antigen 3 Test Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Prostate Cancer Antigen 3 Test Market Analysis by Regions

4.1 Prostate Cancer Antigen 3 Test Overall Market: 2023 VS 2024 VS 2030

4.2 Global Prostate Cancer Antigen 3 Test Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Prostate Cancer Antigen 3 Test Revenue and Market Share by Region (2019-2024)

4.2.2 Global Prostate Cancer Antigen 3 Test Revenue Forecast by Region (2025-2030)

5 Global Prostate Cancer Antigen 3 Test Market Size by Type and Application

5.1 Global Prostate Cancer Antigen 3 Test Market Size by Type

5.2 Global Prostate Cancer Antigen 3 Test Market Size by Application

6 North America

6.1 North America Prostate Cancer Antigen 3 Test Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Prostate Cancer Antigen 3 Test Market Size by Type

6.4 North America Prostate Cancer Antigen 3 Test Market Size by Application

6.5 North America Prostate Cancer Antigen 3 Test Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Prostate Cancer Antigen 3 Test Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Prostate Cancer Antigen 3 Test Market Size by Type

7.4 Europe Prostate Cancer Antigen 3 Test Market Size by Application

7.5 Europe Prostate Cancer Antigen 3 Test Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Prostate Cancer Antigen 3 Test Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Prostate Cancer Antigen 3 Test Market Size by Type

8.4 China Prostate Cancer Antigen 3 Test Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Prostate Cancer Antigen 3 Test Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Prostate Cancer Antigen 3 Test Market Size by Type

9.4 APAC (excl. China) Prostate Cancer Antigen 3 Test Market Size by Application

9.5 APAC (excl. China) Prostate Cancer Antigen 3 Test Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Prostate Cancer Antigen 3 Test Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Prostate Cancer Antigen 3 Test Market Size by Type

10.4 Latin America Prostate Cancer Antigen 3 Test Market Size by Application

10.5 Latin America Prostate Cancer Antigen 3 Test Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Prostate Cancer Antigen 3 Test Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Prostate Cancer Antigen 3 Test Market Size by Type

11.4 Middle East & Africa Prostate Cancer Antigen 3 Test Market Size by Application

11.5 Middle East & Africa Prostate Cancer Antigen 3 Test Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Prostate Cancer Antigen 3 Test Market Revenue by Key Manufacturers (2020-2024)

12.2 Prostate Cancer Antigen 3 Test Competitive Landscape Analysis and Market Dynamic

12.2.1 Prostate Cancer Antigen 3 Test Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 MDxHealth

13.1.1 MDxHealth Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 MDxHealth Prostate Cancer Antigen 3 Test Product Portfolio

13.1.3 MDxHealth Prostate Cancer Antigen 3 Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Myriad Genetics, Inc

13.2.1 Myriad Genetics, Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Myriad Genetics, Inc Prostate Cancer Antigen 3 Test Product Portfolio

13.2.3 Myriad Genetics, Inc Prostate Cancer Antigen 3 Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Abbott

13.3.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Abbott Prostate Cancer Antigen 3 Test Product Portfolio

13.3.3 Abbott Prostate Cancer Antigen 3 Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 F. Hoffmann-La Roche Ltd

13.4.1 F. Hoffmann-La Roche Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 F. Hoffmann-La Roche Ltd Prostate Cancer Antigen 3 Test Product Portfolio

13.4.3 F. Hoffmann-La Roche Ltd Prostate Cancer Antigen 3 Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Siemens

13.5.1 Siemens Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Siemens Prostate Cancer Antigen 3 Test Product Portfolio

13.5.3 Siemens Prostate Cancer Antigen 3 Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 OPKO Health, Inc

13.6.1 OPKO Health, Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 OPKO Health, Inc Prostate Cancer Antigen 3 Test Product Portfolio

13.6.3 OPKO Health, Inc Prostate Cancer Antigen 3 Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Genomic Health

13.7.1 Genomic Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Genomic Health Prostate Cancer Antigen 3 Test Product Portfolio

13.7.3 Genomic Health Prostate Cancer Antigen 3 Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 BD

13.8.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 BD Prostate Cancer Antigen 3 Test Product Portfolio

13.8.3 BD Prostate Cancer Antigen 3 Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Agilent Technologies, Inc

13.9.1 Agilent Technologies, Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Agilent Technologies, Inc Prostate Cancer Antigen 3 Test Product Portfolio

13.9.3 Agilent Technologies, Inc Prostate Cancer Antigen 3 Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Danaher

13.10.1 Danaher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Danaher Prostate Cancer Antigen 3 Test Product Portfolio

13.10.3 Danaher Prostate Cancer Antigen 3 Test Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Prostate Cancer Antigen 3 Test Industry Chain Analysis

14.2 Prostate Cancer Antigen 3 Test Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Prostate Cancer Antigen 3 Test Typical Downstream Customers

14.4 Prostate Cancer Antigen 3 Test Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support